Vinay Enumula

Vinay Enumula

Auto-generated profile, based on publicly available information

Vinay Enumula

Department of Pharmacology, National Research Institute of Unani medicine for skin disorders (Formerly central research institute of Unani medicine), Opposite ESI Hospital, AG Colony Road, Erragadda, Hyderabad-500038, Telangana State, India

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2021 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
ABArchana B
Archana B
RMRavi Naik Mudavath
Ravi Naik Mudavath
VEVinay Enumula
Vinay Enumula
NRN Ravali
N Ravali
PKPaka Sravan Kumar
Paka Sravan Kumar
The report used to be planned to analyze the antiepileptic activity of Cocos nucifera flowers against special experimentally induced convulsions in rats. In the present study, antiepileptic activity was assessed by following experimental models. Anti-convulsant in vivo models: Maximal electroshocks (MES) induced models in rats, Pentylenetetrazole (PTZ) induced in rats. Pretreatment of animals with Cocos nucifera flowers extract has reduced by half the general continuance of tonic hind leg extension, the most commonly used endpoint in assessing clonic convulsions. MES provokes repetitive neuronal firing indicates epileptic neurons. MES is the widely accepted model to demonstrate the antiepileptic property of a drug. This property is antagonistic of the plant extract could flow from to blockade of voltage-gated sodium channel or due to effect on NMDA receptors. The Cocos nucifera flowers extract was also demonstrated potential anticonvulsant activity in PTZ induced convulsions and this may be due to its agonistic activity on the GABAA receptor. This is further supported by an elevated level of GABA by the plant extract in the PTZ model. Methanolic extract of Cocos nucifera flowers has shown significant anticonvulsant activity against MES and Pentlylenetetrazole induced convulsion models. This observed activity could also be the referable presence of flavonoids and other phytochemical constituents found in the powerful extract. Keywords: Cocos nucifera, antiepileptic activity, Maximal electroshock, Pentlylenetetrazole, Flavonoids,

1 January 2021 in The Natural Products Journal
Verified
Journal Article
Closed access
PDF file
PNPrasad Neerati
Prasad Neerati
VEVinay Enumula
Vinay Enumula
Aim and Background: Amytriptiline (AMY), an antidepressant, is used in the treatment of neuropathic pain. However, with limited therapeutic benefits and side effects of AMY, it is not helpful to the majority of the neuropathic pain patients. Gallic acid (GA) is a polyphenolic product with potential antioxidant effects, useful in neuropathic pain. Objective: The purpose of the study was to investigate the improved neuropathic pain relief with GA in combination with AMY in rats. Methods: Partial sciatic nerve ligation (PSNL) method is used for neuropathic pain induction in rats. The rats were randomly divided into 6 groups (n = 8), and treated with drugs or vehicle once daily for 15 days after the pain induction. The first group served as Normal control and received normal saline (p.o), the second group served as Sham Control and received Normal Saline (p.o), the third group served as Surgery Control and received normal saline (p.o), the fourth group received AMY (25mg/kg, p.o), while the fifth group received GA (100mg/kg,p.o), and the sixth group received both AMY and GA. Further behavioural studies for pain were carried out on days 1,4,7,10,13,16,19 and 22. Histological studies of sciatic nerves were carried out on days 1, 15 and 22, and on the 22nd day, all the remaining animals were sacrificed for the biochemical estimations of the sciatic nerve tissues. Results: GA attenuates neuropathic pain better in combination with AMY by ameliorating the behavioral, biochemical and histopathological signs and symptoms. This resultant effect is due to its antioxidant, antinociceptive and anti-inflammatory actions. It also potentiates AMY antinociceptive and antioxidant effects when given in combination in a continuous treatment. Conclusion: The results suggest that GA in combination with AMYattenuated the neuropathic pain. Hence, the use of GA as an adjunctive with AMY in the neuropathic pain will be more therapeutically beneficial; further studies on patients to confirm the results are warranted.

1 January 2025 in Natural Resources for Human Health
Verified
Journal Article
Open access
TATabrez Ahmed
Tabrez Ahmed
EVEnumula Vinay
Enumula Vinay
MNMohammed Abdul Rasheed Naikodi
Mohammed Abdul Rasheed Naikodi
JSJaved Inam Siddiqui
Javed Inam Siddiqui
DDDurgesh Dwivedi
Durgesh Dwivedi
GHGulam Mohammed Husain
Gulam Mohammed Husain
A polyherbal Unani formulation, Qurs-e-Ziabetus (QZ), is mentioned in Unani literature for managing diabetes-like conditions. This study aimed to evaluate the antidiabetic activity of QZ, which is mentioned in classical Unani literature, in nicotinamide-streptozotocin-induced diabetes in Sprague Dawley rats. Preliminary phytochemical screening of QZ and HPTLC fingerprint profile was developed. An oral glucose tolerance test (OGTT) was performed in normal euglycemic SD rats. Further, antihyperglycemic potential was tested in nicotinamide-streptozotocin-induced diabetic rats. Treatment of QZ (250, 500, and 1000 mg/kg) and glibenclamide (10 mg/kg) was provided for 28 days. After 28 days, all the rats had fasted overnight, and blood samples were collected and subjected to biochemical estimation and hematology parameters. The pancreas, liver, and kidneys were collected, and histopathological analysis was performed. Various phytoconstituents are detected in QZ. In OGTT, QZ treatment did not significantly decrease blood glucose levels in rats challenged with glucose (2 gm/kg). On day 28 in the nicotinamide-streptozotocin-induced diabetes model, the QZ showed a significant dose-dependent fasting blood glucose lowering effect compared to diabetic control. QZ and glibenclamide treatment did not affect the body weights or biochemical and hematology parameters of nicotinamide-streptozotocin-induced diabetic rats. Histological analyses of the pancreas, liver, and kidney were observed, with some changes in the diabetic group compared to normal control. At the same time, QZ treatment revealed improved histopathological changes induced by Streptozotocin and further diabetic conditions. The study data demonstrates the antihyperglycemic potential of QZ up on administration for 28 days in nicotinamide-streptozotocin-induced diabetic rats.